Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America AI in Pathology Market, by Neural Network
1.4.2 North America AI in Pathology Market, by Application
1.4.3 North America AI in Pathology Market, by End User
1.4.4 North America AI in Pathology Market, by Component
1.4.5 North America AI in Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Recent Strategies Deployed in AI in Pathology Market
4.3 Porter’s Five Forces Analysis
Chapter 5. North America AI in Pathology Market, By Neural Network
5.1 North America Convolutional neural networks (CNNs) Market, By Country
5.2 North America Generative adversarial networks (GANs) Market, By Country
5.3 North America Recurrent neural networks (RNNs) Market, By Country
5.4 North America Others Market, By Country
Chapter 6. North America AI in Pathology Market, By Application
6.1 North America Drug Discovery Market, By Country
6.2 North America Disease Diagnosis & Prognosis Market, By Country
6.3 North America Clinical Workflow Market, By Country
6.4 North America Others Market, By Country
Chapter 7. North America AI in Pathology Market, By End User
7.1 North America Pharmaceutical & Biotechnology Companies Market, By Country
7.2 North America Hospitals & Reference Laboratories Market, By Country
7.3 North America Academic & Research Institutes Market, By Country
Chapter 8. North America AI in Pathology Market, By Component
8.1 North America Scanners Market, By Country
8.2 North America Software Market, By Country
Chapter 9. North America AI in Pathology Market, By Country
9.1 US AI in Pathology Market
9.1.1 US AI in Pathology Market, By Neural Network
9.1.2 US AI in Pathology Market, By Application
9.1.3 US AI in Pathology Market, By End User
9.1.4 US AI in Pathology Market, By Component
9.2 Canada AI in Pathology Market
9.2.1 Canada AI in Pathology Market, By Neural Network
9.2.2 Canada AI in Pathology Market, By Application
9.2.3 Canada AI in Pathology Market, By End User
9.2.4 Canada AI in Pathology Market, By Component
9.3 Mexico AI in Pathology Market
9.3.1 Mexico AI in Pathology Market, By Neural Network
9.3.2 Mexico AI in Pathology Market, By Application
9.3.3 Mexico AI in Pathology Market, By End User
9.3.4 Mexico AI in Pathology Market, By Component
9.4 Rest of North America AI in Pathology Market
9.4.1 Rest of North America AI in Pathology Market, By Neural Network
9.4.2 Rest of North America AI in Pathology Market, By Application
9.4.3 Rest of North America AI in Pathology Market, By End User
9.4.4 Rest of North America AI in Pathology Market, By Component
Chapter 10. Company Profiles
10.1 Koninklijke Philips N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.6 SWOT Analysis
10.3 Hologic, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Visiopharm A/S
10.4.1 Company Overview
10.4.2 Recent strategies and developments:
10.4.2.1 Partnerships, Collaborations, and Agreements:
10.4.3 SWOT Analysis
10.5 Paige AI, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Partnerships, Collaborations, and Agreements:
10.5.2.2 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 PathAI, Inc.
10.6.1 Company Overview
10.6.2 Recent strategies and developments:
10.6.2.1 Partnerships, Collaborations, and Agreements:
10.6.3 SWOT Analysis
10.7 Aiforia Technologies Plc
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Recent strategies and developments:
10.7.3.1 Partnerships, Collaborations, and Agreements:
10.7.4 SWOT Analysis
10.8 Indica Labs, Inc.
10.8.1 Company Overview
10.8.2 Recent strategies and developments:
10.8.2.1 Partnerships, Collaborations, and Agreements:
10.8.3 SWOT Analysis
10.9 Optrascan, Inc. (Optra Ventures, LLC)
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Product Launches and Product Expansions:
10.9.3 SWOT Analysis
10.10. MindPeak GmbH
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:
10.10.3 SWOT Analysis
Unique Offerings 